Clinical trial
Evaluating the Impact of Perioperative Antibiotic Prophylaxis on the Microbiome in Patients With Cutaneous Malignancy
NCT04875728 is registered in ClinicalTrials.gov with M.D. Anderson Cancer Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluating the Impact of Perioperative Antibiotic Prophylaxis on the Microbiome in Patients With Cutaneous Malignancy
- Lead sponsor
- M.D. Anderson Cancer Center
- Phase
- Phase 1
- Overall status
- Active, not recruiting
- Start date
- September 8, 2020
- Completion date
- February 2, 2027
- Enrollment
- 20 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
clinical stage i cutaneous melanoma ajcc v8, clinical stage ia cutaneous melanoma ajcc v8, clinical stage ib cutaneous melanoma ajcc v8, clinical stage ii cutaneous melanoma ajcc v8, clinical stage iia cutaneous melanoma ajcc v8, clinical stage iib cutaneous melanoma ajcc v8, clinical stage iic cutaneous melanoma ajcc v8, pathologic stage i cutaneous melanoma ajcc v8, pathologic stage ia cutaneous melanoma ajcc v8, pathologic stage ib cutaneous melanoma ajcc v8, pathologic stage ii cutaneous melanoma ajcc v8, pathologic stage iia cutaneous melanoma ajcc v8, pathologic stage iib cutaneous melanoma ajcc v8, pathologic stage iic cutaneous melanoma ajcc v8